Diversified Trust CO Acadia Pharmaceuticals Inc Transaction History

Diversified Trust CO

$3.27 Billion
Q3 2024

A detailed history of Diversified Trust CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Diversified Trust CO holds 32,587 shares of ACAD stock, worth $549,742. This represents 0.02% of its overall portfolio holdings.

Number of Shares

32,587

Previous 32,545 0.13%

Holding current value

$549,742

Previous $528,000 5.11%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$15.14 - $19.14 $635 - $803	42 Added 0.13%	32,587 $501,000
Q2 2024 Jul 16, 2024	BUY	$14.62 - $18.42 $24,561 - $30,945	1,680 Added 5.44%	32,545 $528,000
Q1 2024 Apr 18, 2024	BUY	$17.79 - $30.86 $32,484 - $56,350	1,826 Added 6.29%	30,865 $570,000
Q4 2023 Jan 08, 2024	SELL	$20.78 - $31.77 $11,865 - $18,140	-571 Reduced 1.93%	29,039 $909,000
Q3 2023 Nov 17, 2023	BUY	$20.84 - $33.47 $50,891 - $81,733	2,442 Added 8.99%	29,610 $617,000
Q2 2023 Jul 18, 2023	SELL	$17.8 - $25.65 $90,584 - $130,532	-5,089 Reduced 15.78%	27,168 $650,000
Q1 2023 Apr 07, 2023	BUY	$16.32 - $20.92 $104,627 - $134,118	6,411 Added 24.8%	32,257 $607,000
Q4 2022 Jan 17, 2023	SELL	$14.2 - $18.63 $6,787 - $8,905	-478 Reduced 1.82%	25,846 $411,000
Q3 2022 Oct 14, 2022	BUY	$14.11 - $18.27 $211 - $274	15 Added 0.06%	26,324 $431,000
Q2 2022 Jul 12, 2022	BUY	$13.01 - $27.22 $71,086 - $148,730	5,464 Added 26.21%	26,309 $371,000
Q1 2022 Apr 07, 2022	SELL	$20.94 - $27.5 $10,197 - $13,392	-487 Reduced 2.28%	20,845 $505,000
Q4 2021 Jan 13, 2022	SELL	$16.79 - $27.09 $36,870 - $59,489	-2,196 Reduced 9.33%	21,332 $498,000
Q3 2021 Jan 13, 2022	BUY	$15.78 - $24.77 $102,333 - $160,633	6,485 Added 38.05%	23,528 $391,000
Q2 2021 Jul 20, 2021	BUY	$19.4 - $27.42 $330,634 - $467,319	17,043 New	17,043 $416,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.73B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.

Account

Diversified Trust CO Acadia Pharmaceuticals Inc Transaction History